首页 | 官方网站   微博 | 高级检索  
     

热疗联合125I粒子治疗复发性直肠癌的近期疗效评价
引用本文:王溪,韩今华,李云峰,杨艳明.热疗联合125I粒子治疗复发性直肠癌的近期疗效评价[J].吉林大学学报(医学版),2017,43(5):963-966.
作者姓名:王溪  韩今华  李云峰  杨艳明
作者单位:吉林大学第二医院放疗科,吉林长春,130041;吉林大学第二医院放疗科,吉林长春,130041;吉林大学第二医院放疗科,吉林长春,130041;吉林大学第二医院放疗科,吉林长春,130041
基金项目:国家自然科学基金青年基金资助课题
摘    要:目的:通过比较复发性直肠癌患者治疗前、后影像学和血清中癌胚抗原(CEA)以及术后随访结果,评价热疗联合125I放射性粒子治疗直肠癌的有效性。方法:手术且放疗后行CT引导下125I放射性粒子植入术(20例手术治疗患者,1例患者无法耐受热疗退出),术前应用放射性粒子治疗计划系统(TPS)制定粒子植入计划,粒子间距为1.0 cm,植入后立即复查CT,再行剂量验证,植入粒子数量为12~58颗,每颗粒子放射性活度为0.5 mCi,肿瘤周边匹配剂量为90~140 Gy。射频热疗,每次60 min,维持温度43℃,每周2次,连续3周。治疗后随访3个月,通过影像学结果和血清中CEA水平变化评价有效率,并评估尿频、尿痛、血尿和直肠出血等并发症。结果:与治疗前比较,随访6个月后影像学结果显示肿瘤缩小;患者治疗后血清中CEA水平由治疗前(30.25±8.32) mg·L-1降低到(11.89±5.22) mg·L-1t=13.158,P < 0.01);局部有效率94.7%(18/19),疼痛缓解率为94.4%(17/18);治疗前NRS评分中位数为6(4,7)分,治疗后NRS评分中位数为1(0,3)分,治疗前后比较差异有统计学意义(P < 0.01)。随访期间患者未出现尿频、尿痛、血尿和直肠出血等并发症。结论:热疗联合125I放射性粒子植入对复发性直肠癌具有较好的临床效果,是复发性直肠癌有效的综合治疗手段。

关 键 词:热疗  125I放射性粒子  直肠肿瘤  复发
收稿时间:2016-11-30

Observation on short-term efficacy of thermal-therapy combined with 125I particles in treatment of recurrent rectal cancer
WANG XI,HAN Jinhua,LI Yunfeng,YANG Yanming.Observation on short-term efficacy of thermal-therapy combined with 125I particles in treatment of recurrent rectal cancer[J].Journal of Jilin University: Med Ed,2017,43(5):963-966.
Authors:WANG XI  HAN Jinhua  LI Yunfeng  YANG Yanming
Affiliation:Department of Radiotherapy, Second Hospital, Jilin University, Changchun 130041, China
Abstract:Objective:To evaluate the clinical efficacy of thermal-therapy combined with 125 I radioactive particles by comparing the results of preoperative and postoperative images,serum carcino-embryonic antigen (CEA) and following-up after treatment of the patients with recurrent rectal cancer.Methods:Nineteen rectal cancer patients with postoperative recurrence after radiotherapy were treated with 125I implantation guided by CT (20 cases were treated with operation,but 1 patient was exited who couldn't tolerate the thermal-therapy).Radioactive particle treatment planning system (TPS) was used to make the plan before the particle implantation,and the distance of the particle was 1.0 cm;all patients received CT scanning and were quantificationally evaluatated after implantation;the number of seeded particles was about 12-58,the radioactivity of the 125I particle was 0.5 mCi,and the matching dose surrounding the tumor was 90-140 Gy.All patients were treated with microwave thermal-therapy after particle implantation,60 min per time,lasting the temprature at 43℃,twice per week,for three weeks.And the patients were followed up after treatment for 3 months,the efficacy was evaluated by image and CEA results,and the urinary frequency,dysuria,hematuria and rectal bleeding were evaluated.Results:Compred with before treatment,after following up for 6 months,the image results showed that the tumor volume was reduced,and the blood CEA level of all patients were decreased from (30.25±8.32) mg · L-1 to (11.89±5.22) mg · L-1 (t=13.158,P<0.01);the local efficacy was 94.7% (18/19),and the pain relief rate was 94.4% (17/18);the NRS median was 6 (4,7) before treatment,and it was 1 (0,3) after treatment,there was significant difference (P<0.001).There were no frequent urination,urinary pain,hematuria,rectal bleeding and other complications in all patients.Conclusion:Thermal-therapy combined with 125I radioactive particle implantation has good curative effects on the recurrent rectum cancer,and is effective means for recurrent rectum cancer treatment.
Keywords:thermal-therapy  125I radioactive particles  rectal neoplasma  recurrence
本文献已被 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号